Abstract-␥-Melanocyte-stimulating hormone (␥-MSH) is a natriuretic peptide derived from proopiomelanocortin (POMC) in the pituitary neurointermediate lobe (NIL); its plasma concentration in rats doubles after ingestion of a high (HSD; 8% NaCl) compared with a low sodium diet (LSD; 0.07%). Because NIL function is regulated through dopaminergic pathways, we asked whether dopaminergic stimulation with bromocriptine (5 mg/kg IP daily for 1 week) or inhibition with haloperidol (5 mg/kg IP for 1 week) alters the ␥-MSH response to a HSD. In vehicle-treated rats, plasma ␥-MSH and NIL ␥-MSH content on the HSD were both markedly elevated over values in rats on the LSD (PϽ0.001); no difference in mean arterial pressure (MAP) occurred. In haloperidol-treated rats on the LSD, both plasma ␥-MSH and NIL ␥-MSH content were greater than in vehicle-treated rats (PϽ0.05) and did not increase further on the HSD; MAP was also no different. In bromocriptine-treated rats, neither plasma ␥-MSH nor NIL ␥-MSH content increased on the HSD versus LSD, and MAP was markedly elevated on the HSD ( Key Words: natriuretic peptides Ⅲ pituitary Ⅲ hypertension, sodium-dependent Ⅲ dopamine M elanocyte-stimulating hormones (MSHs) are peptides of ␣, , and ␥ primary structure, which are derived from the ACTH/-endorphin precursor proopiomelanocortin (POMC). Identified initially from the property of ␣-and -MSH to induce melanin dispersion in melanocytes of fish and amphibians, they are highly conserved in mammalian species, where their pigmentary function is minor. This has suggested that they may serve other important biological functions, and roles in inflammation, temperature regulation, satiety, and cardiovascular control have all been indicated. [1][2][3][4] Each of the MSH peptides is also natriuretic, 5-8 and the plasma concentration and pituitary content of ␥-MSH immunoreactivity increase in rats fed a high sodium diet (HSD). 9,10 Additional support for a role in sodium homeostasis comes from the observations that an HSD increases the mRNA abundance of POMC and of the prohormone convertase enzymes PC1 and PC2 involved in its processing into ␥-MSH in the neurointermediate (NIL) of rat pituitary but not the anterior lobe (AL). 9,10 We have recently observed that genetic deficiency of circulating ␥-MSH caused by disruption of the PC2 gene is accompanied by marked salt-sensitive hypertension, 11 further suggesting an important role of this peptide in sodium metabolism and blood pressure control.POMC synthesis and processing in the NIL are under tonic dopaminergic suppression through the dopamine D 2 receptor 12,13 ; the dopamine agonist bromocriptine suppresses the synthesis of POMC and the processing enzymes PC1 and PC2, whereas the dopamine receptor antagonist haloperidol does the opposite. 14, 15 We asked if dopaminergic manipulation modified in any way the action of a diet high in sodium content to stimulate the abundance of NIL ␥-MSH content and the plasma concentration of ␥-MSH, and, if so, what effect this would have on blood pressure and s...